Related Experiment Video
Updated: Jul 15, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
Published on: July 3, 2026
Dexamethasone does not alter in vitro antibacterial efficacy of gentamicin
Michael T Drobbin1, Sean T Phelan, Patrick J Antonelli
1Department of Otolaryngology, University of Florida, Gainesville, FL 32610, USA.
Objectives:
Aminoglycoside ototoxicity may be mitigated by administration of dexamethasone; however, dexamethasone could theoretically impair its antibacterial properties. The purpose of this experiment was to determine if dexamethasone decreases the antibacterial activity of gentamicin against Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA).
Study Design:
In vitro microbiological assay.
Methods:
Four separate trials of minimum inhibitory concentration (MIC) testing were performed for gentamicin against five PA strains and six SA strains, with and without the addition of high and low concentrations of dexamethasone.
Results:
MICs were not changed by more than one dilution with the addition of either high or low concentrations of dexamethasone for any of the PA and SA strains.
Conclusion:
Dexamethasone does not impair the antibacterial efficacy of gentamicin for PA and SA. This supports the role of dexamethasone as an oto-protectant with aminoglycoside therapy.
Insights
Dexamethasone does not reduce gentamicin's effectiveness against Pseudomonas aeruginosa and Staphylococcus aureus. This finding supports using dexamethasone to protect against aminoglycoside-induced hearing loss.
Area of Science:
- Microbiology
- Pharmacology
Background:
- Aminoglycoside antibiotics can cause ototoxicity (hearing damage).
- Dexamethasone may mitigate aminoglycoside ototoxicity.
- Concerns exist that dexamethasone might reduce antibiotic effectiveness.
Purpose of the Study:
- To investigate if dexamethasone impacts gentamicin's antibacterial activity.
- To assess gentamicin efficacy against Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) with dexamethasone co-administration.
Main Methods:
- In vitro microbiological assay.
- Minimum Inhibitory Concentration (MIC) testing.
- Tested gentamicin against multiple strains of PA and SA, with and without varying concentrations of dexamethasone.
Main Results:
- Dexamethasone, at both high and low concentrations, did not alter the MIC of gentamicin for PA and SA strains by more than one dilution.
- No significant decrease in gentamicin's antibacterial activity was observed in the presence of dexamethasone.
Conclusions:
- Dexamethasone does not impair the antibacterial efficacy of gentamicin against PA and SA.
- These results support the use of dexamethasone as a protective agent against aminoglycoside-induced ototoxicity.
- Co-administration of dexamethasone with gentamicin is a viable therapeutic strategy.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Inhibitors of Bacterial Protein Synthesis
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Antimicrobial Effectiveness
Inhibitors of Gram-positive Cell Wall Synthesis
